Company / Depreciation & Amortization
Harmony Biosciences Holdings, Inc. Depreciation & Amortization History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$395.0K
FY2021
5-year range
$395.0K / $395.0K
FY2019-FY2021
Trend
+0.0%
vs FY2020
Sector context
#137 of 163
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s depreciation & amortization of $395,000 is lower than 84% of companies in the Health Care sector (FY2021). Depreciation & Amortization remained relatively stable over the past 3 years, with values between $395,000 and $395,000.
Based on SEC 10-K filings.
$395,000 in FY2021.
Remained stable around $395,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.8% below sector average
Key checks
Key Insights
- In FY2021, depreciation & amortization increased 0.0% year-over-year.
- Ranks #137 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $395.0K | +0.0% |
| FY2020 | $395.0K | +0.0% |
| FY2019 | $395.0K | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026